Druggio Logo

Druggio

GlaxoSmithKline

GlaxoSmithKline is a pharmaceutical company founded in 2000 through a merger of Glaxo Wellcome and SmithKline Beecham. The company focuses on the development of prescription medicines, vaccines, and consumer healthcare products. Their drug portfolio includes treatments for a wide range of diseases, including respiratory, HIV, oncology, and infectious diseases. They also have a strong presence in the development of vaccines and healthcare products. Overall, GlaxoSmithKline is known for its extensive research and development efforts in the healthcare sector.

GlaxoSmithKline's Drugs

Xevudy

Approval date

2021/9/27

Treats

COVID-19
Duvroq

Approval date

2020/6/29

Treats

Renal anemia
Benlysta

Approval date

2017/9/27

Nucala

Approval date

2016/3/28

Encruse

Approval date

2015/3/26

Anoro

Approval date

2014/7/4

Tenozet

Approval date

2014/3/24

Relvar

Approval date

2013/9/20

Arzerra

Approval date

2013/3/25

Malarone

Approval date

2012/12/25

Treats

Malaria
Votrient

Approval date

2012/9/28

Samtirel

Approval date

2012/1/18

Rotarix

Approval date

2011/7/1

Xyzal

Approval date

2010/10/27

Revolade

Approval date

2010/10/27

Volibris

Approval date

2010/7/23

Arepanrix

Approval date

2010/1/20

Cervarix

Approval date

2009/10/16

Avolve

Approval date

2009/7/7

Allermist

Approval date

2009/4/22

Tykerb

Approval date

2009/4/22

Lamictal

Approval date

2008/10/16

Amerge

Approval date

2008/1/25

Arranon G

Approval date

2007/10/19

Arixtra

Approval date

2007/4/18

ReQuip

Approval date

2006/10/20

Lexiva

Approval date

2004/12/24

Hepsera, Zefix

Approval date

2004/10/22

Serevent

Approval date

2002/4/11

Hycamtin

Approval date

2000/12/22

Zefix

Approval date

2000/9/22

Imigran

Approval date

2000/1/18